Resolian, a renowned global leader in delivering bioanalytical, DMPK, and CMC testing services to the pharmaceutical and biopharmaceutical industry, proudly inaugurates its expansive 440m² analytical laboratory located in Fordham, Cambridgeshire, UK.
This new laboratory, whose plans were unveiled earlier this year, boasts a 30% increase in space, providing enhanced capacity to address the growing demand for analytical and materials science endeavors.
“We are thrilled to have expanded our laboratory in Fordham by more than 30% to effectively cater to the escalating demand,” expressed Ellen Stokvis, Director of Analytical Sciences Operations. “Our newly constructed, state-of-the-art lab fortifies our analytical and materials science capabilities. The augmentation of lab space from 330m² to 440m² facilitates the opportunity for more companies to collaborate with us.
“The design of the new laboratory space fosters improved collaboration, workflow, and traffic management. In conjunction with our Sandwich site, this investment in the analytical and materials science domain of our operations ensures that we are well-prepared to meet the current and future demands of our valued customers.”
To learn more about Resolian’s continuous evolution in providing specialised support throughout the global drug development continuum, visit the company’s newly launched website.
